Association of High Levels of Plasma OX40 with Acute Adult T-cell Leukemia

Overview

Journal Int J Hematol

Specialty Hematology

Date 2019 Jan 18

PMID 30652238

Citations 5

Authors

Yuetsu Tanaka

Yoshiaki Takahashi

Reiko Tanaka

Takuya Miyagi

Mineki Saito

Takuya Fukushima

Affiliations

Soon will be listed here.

Abstract

OX40, a member of the tumor necrosis factor receptor (TNFR) superfamily, co-stimulates activated T cells following interaction with its own ligand OX40L. Human T-cell leukemia virus type-1 (HTLV-1) is an etiological agent of adult T-cell leukemia (ATL). ATL cells are known to express cell surface OX40; however, the level of soluble OX40 (sOX40) in blood samples from ATL patients is unknown. Quantitative enzyme-linked immune-sorbent assay (ELISA) showed that sOX40 levels were significantly higher in plasma from acute ATL patients than those from asymptomatic HTLV-1 carriers and healthy donors, and correlated with sCD25 levels and HTLV-1 proviral loads in peripheral blood mononuclear cells (PBMCs). Fresh PBMCs from acute ATL patients showed a higher percentage of OX40-positive cells compared with those from carriers, and shed sOX40 into culture supernatants. Shedding of sOX40 was partially inhibited by a matrix metalloproteinase (MMP) inhibitor, GM6001. A fraction of sOX40 was capable of binding to OX40L. These results suggest that high levels of sOX40 are shed into blood from a large number of ATL cells in acute ATL patients. Thus, abnormally elevated plasma sOX40 levels may be useful as an additional diagnostic marker of acute ATL.

Citing Articles

Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications.

Chen L, Chao Y, Li W, Wu Z, Wang Q Biomark Res. 2024; 12(1):95.

PMID: 39218939 PMC: 11368031. DOI: 10.1186/s40364-024-00647-0.

Elevation of the Plasma Levels of TNF Receptor 2 in Association with Those of CD25, OX40, and IL-10 and HTLV-1 Proviral Load in Acute Adult T-Cell Leukemia.

Kato M, Imaizumi N, Tanaka R, Mizuguchi M, Hayashi M, Miyagi T Viruses. 2022; 14(4).

PMID: 35458481 PMC: 9032861. DOI: 10.3390/v14040751.

Serum Levels of OX40 in Early and Late-Stage Oral Squamous Cell Carcinoma.

Sani A, Rubab Z, Usman S, Ahmed S, Hosein M, Shahid M Cureus. 2021; 13(4):e14597.

PMID: 34036015 PMC: 8137365. DOI: 10.7759/cureus.14597.

Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.

Guerrero C, Yamashita Y, Miyara M, Imaizumi N, Kato M, Sakihama S Blood Adv. 2020; 4(6):1062-1071.

PMID: 32196559 PMC: 7094015. DOI: 10.1182/bloodadvances.2019001429.

Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment.

Ratner L Front Microbiol. 2019; 10:2109.

PMID: 31620102 PMC: 6759749. DOI: 10.3389/fmicb.2019.02109.

References

Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T . Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1999; 4(6):586-93. DOI: 10.3109/13550289809114225. View

Takasawa N, Ishii N, Higashimura N, Murata K, Tanaka Y, Nakamura M . Expression of gp34 (OX40 ligand) and OX40 on human T cell clones. Jpn J Cancer Res. 2001; 92(4):377-82. PMC: 5926725. DOI: 10.1111/j.1349-7006.2001.tb01105.x. View

Tanaka R, Yoshida A, Murakami T, Baba E, Lichtenfeld J, Omori T . Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection. J Virol. 2001; 75(23):11534-43. PMC: 114740. DOI: 10.1128/JVI.75.23.11534-11543.2001. View

Mori N, Sato H, Hayashibara T, Senba M, Hayashi T, Yamada Y . Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood. 2002; 99(4):1341-9. DOI: 10.1182/blood.v99.4.1341. View

Tashiro T, Yamasaki T, Nagai H, Kikuchi H, Nasu M . Immunological studies on opportunistic infection and the development of adult T-cell leukemia. Intern Med. 1992; 31(9):1132-6. DOI: 10.2169/internalmedicine.31.1132. View

Ma B, Mikolajczak S, Danesh A, Hosiawa K, Cameron C, Takaori-Kondo A . The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. Blood. 2005; 106(6):2002-10. DOI: 10.1182/blood-2004-04-1622. View

Hintzen R, de Jong R, Hack C, Chamuleau M, de Vries E, ten Berge I . A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol. 1991; 147(1):29-35. View

Compaan D, Hymowitz S . The crystal structure of the costimulatory OX40-OX40L complex. Structure. 2006; 14(8):1321-30. DOI: 10.1016/j.str.2006.06.015. View

Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79(3):428-37. DOI: 10.1111/j.1365-2141.1991.tb08051.x. View

10.

Kondo K, Okuma K, Tanaka R, Zhang L, Kodama A, Takahashi Y . Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. Hum Immunol. 2007; 68(7):563-71. DOI: 10.1016/j.humimm.2007.03.012. View

11.

Pichler K, Kattan T, Gentzsch J, Kress A, Taylor G, Bangham C . Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein. Blood. 2008; 111(9):4741-51. DOI: 10.1182/blood-2007-10-115220. View

12.

Takahashi Y, Tanaka R, Yamamoto N, Tanaka Y . Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production. AIDS Res Hum Retroviruses. 2008; 24(3):423-35. DOI: 10.1089/aid.2007.0092. View

13.

Croft M, So T, Duan W, Soroosh P . The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev. 2009; 229(1):173-91. PMC: 2729757. DOI: 10.1111/j.1600-065X.2009.00766.x. View

14.

Croft M . Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol. 2010; 28:57-78. PMC: 2882161. DOI: 10.1146/annurev-immunol-030409-101243. View

15.

Hayashida K, Bartlett A, Chen Y, Park P . Molecular and cellular mechanisms of ectodomain shedding. Anat Rec (Hoboken). 2010; 293(6):925-37. PMC: 4621804. DOI: 10.1002/ar.20757. View

16.

Ishii N, Takahashi T, Soroosh P, Sugamura K . OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010; 105:63-98. DOI: 10.1016/S0065-2776(10)05003-0. View

17.

Tanaka R, Takahashi Y, Kodama A, Saito M, Ansari A, Tanaka Y . Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines. AIDS Res Hum Retroviruses. 2010; 26(10):1147-54. DOI: 10.1089/aid.2010.0043. View

18.

Nakachi S, Nakazato T, Ishikawa C, Kimura R, Mann D, Senba M . Human T-cell leukemia virus type 1 tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling. Biochim Biophys Acta. 2011; 1813(5):731-41. DOI: 10.1016/j.bbamcr.2011.02.002. View

19.

Mallett S, Fossum S, Barclay A . Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor. EMBO J. 1990; 9(4):1063-8. PMC: 551780. DOI: 10.1002/j.1460-2075.1990.tb08211.x. View

20.

Kress A, Grassmann R, Fleckenstein B . Cell surface markers in HTLV-1 pathogenesis. Viruses. 2011; 3(8):1439-59. PMC: 3185802. DOI: 10.3390/v3081439. View